Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine

1,3-Butadiene (BD) is a common environmental and industrial chemical widely used in plastic and rubber manufacturing and also present in cigarette smoke and automobile exhaust. BD is classified as a known human carcinogen based on evidence of carcinogenicity in laboratory animals treated with BD by...

Full description

Bibliographic Details
Main Authors: Luke Erber, Samantha Goodman, Caitlin C. Jokipii Krueger, Ivan Rusyn, Natalia Tretyakova
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/9/10/247
_version_ 1797513059594403840
author Luke Erber
Samantha Goodman
Caitlin C. Jokipii Krueger
Ivan Rusyn
Natalia Tretyakova
author_facet Luke Erber
Samantha Goodman
Caitlin C. Jokipii Krueger
Ivan Rusyn
Natalia Tretyakova
author_sort Luke Erber
collection DOAJ
description 1,3-Butadiene (BD) is a common environmental and industrial chemical widely used in plastic and rubber manufacturing and also present in cigarette smoke and automobile exhaust. BD is classified as a known human carcinogen based on evidence of carcinogenicity in laboratory animals treated with BD by inhalation and epidemiological studies revealing an increased risk of leukemia and lymphohematopoietic cancers in workers occupationally exposed to BD. Upon exposure via inhalation, BD is bioactivated to several toxic epoxides including 3,4-epoxy-1-butene (EB), 3,4-epoxy-1,2-butanediol (EBD), and 1,2,3,4-diepoxybutane (DEB); these are conjugated with glutathione and excreted as 2-(N-acetyl-L-cystein-S-yl)-1-hydroxybut-3-ene/1-(N-acetyl-L-cystein-S-yl)-2-hydroxybut-3-ene (MHBMA), 4-(N-acetyl-L-cystein-S-yl)-1,2-dihydroxybutane (DHBMA), and 1,4-<i>bis</i>-(N-acetyl-L-cystein-S-yl)butane-2,3-diol (<i>bis</i>-BDMA). Exposure to DEB generates monoalkylated DNA adducts, DNA-DNA crosslinks, and DNA-protein crosslinks, which can cause base substitutions, genomic rearrangements, and large genomic deletions. In this study, we developed a quantitative nanoLC/NSI<sup>+</sup>-HRMS methodology for 1,4-<i>bis</i>-(gua-7-yl)-2,3-butanediol (<i>bis</i>-N7G-BD) adducts in urine (LOD: 0.1 fmol/mL urine, LOQ: 1.0 fmol/mL urine). This novel method was used to quantify <i>bis</i>-N7G-BD in urine of mice treated with 590 ± 150 ppm BD for 2 weeks (6 h/day, 5 days/week). <i>Bis</i>-N7G-BD was detected in urine of male and female BD-exposed mice (574.6 ± 206.0 and 571.1 ± 163.4 pg/mg of creatinine, respectively). In addition, major urinary metabolites of BD, <i>bis</i>-BDMA, MHBMA and DHBMA, were measured in the same samples. Urinary <i>bis</i>-N7G-BD adduct levels correlated with DEB-derived metabolite <i>bis</i>-BDMA (<i>r</i> = 0.80, Pearson correlation), but not with the EB-derived DNA adducts (EB-GII) or EB-derived metabolites MHBMA and DHBMA (<i>r</i> = 0.24, <i>r</i> = 0.14, <i>r</i> = 0.18, respectively, Pearson correlations). Urinary <i>bis</i>-N7G-BD could be employed as a novel non-invasive biomarker of exposure to BD and bioactivation to its most mutagenic metabolite, DEB. This method will be useful for future studies of 1,3-butadiene exposure and metabolism.
first_indexed 2024-03-10T06:10:22Z
format Article
id doaj.art-59ee0b9d77924d828d0f4a8d27dcaa83
institution Directory Open Access Journal
issn 2305-6304
language English
last_indexed 2024-03-10T06:10:22Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Toxics
spelling doaj.art-59ee0b9d77924d828d0f4a8d27dcaa832023-11-22T20:12:22ZengMDPI AGToxics2305-63042021-10-0191024710.3390/toxics9100247Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in UrineLuke Erber0Samantha Goodman1Caitlin C. Jokipii Krueger2Ivan Rusyn3Natalia Tretyakova4Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USADepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USADepartment of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USADepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USADepartment of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA1,3-Butadiene (BD) is a common environmental and industrial chemical widely used in plastic and rubber manufacturing and also present in cigarette smoke and automobile exhaust. BD is classified as a known human carcinogen based on evidence of carcinogenicity in laboratory animals treated with BD by inhalation and epidemiological studies revealing an increased risk of leukemia and lymphohematopoietic cancers in workers occupationally exposed to BD. Upon exposure via inhalation, BD is bioactivated to several toxic epoxides including 3,4-epoxy-1-butene (EB), 3,4-epoxy-1,2-butanediol (EBD), and 1,2,3,4-diepoxybutane (DEB); these are conjugated with glutathione and excreted as 2-(N-acetyl-L-cystein-S-yl)-1-hydroxybut-3-ene/1-(N-acetyl-L-cystein-S-yl)-2-hydroxybut-3-ene (MHBMA), 4-(N-acetyl-L-cystein-S-yl)-1,2-dihydroxybutane (DHBMA), and 1,4-<i>bis</i>-(N-acetyl-L-cystein-S-yl)butane-2,3-diol (<i>bis</i>-BDMA). Exposure to DEB generates monoalkylated DNA adducts, DNA-DNA crosslinks, and DNA-protein crosslinks, which can cause base substitutions, genomic rearrangements, and large genomic deletions. In this study, we developed a quantitative nanoLC/NSI<sup>+</sup>-HRMS methodology for 1,4-<i>bis</i>-(gua-7-yl)-2,3-butanediol (<i>bis</i>-N7G-BD) adducts in urine (LOD: 0.1 fmol/mL urine, LOQ: 1.0 fmol/mL urine). This novel method was used to quantify <i>bis</i>-N7G-BD in urine of mice treated with 590 ± 150 ppm BD for 2 weeks (6 h/day, 5 days/week). <i>Bis</i>-N7G-BD was detected in urine of male and female BD-exposed mice (574.6 ± 206.0 and 571.1 ± 163.4 pg/mg of creatinine, respectively). In addition, major urinary metabolites of BD, <i>bis</i>-BDMA, MHBMA and DHBMA, were measured in the same samples. Urinary <i>bis</i>-N7G-BD adduct levels correlated with DEB-derived metabolite <i>bis</i>-BDMA (<i>r</i> = 0.80, Pearson correlation), but not with the EB-derived DNA adducts (EB-GII) or EB-derived metabolites MHBMA and DHBMA (<i>r</i> = 0.24, <i>r</i> = 0.14, <i>r</i> = 0.18, respectively, Pearson correlations). Urinary <i>bis</i>-N7G-BD could be employed as a novel non-invasive biomarker of exposure to BD and bioactivation to its most mutagenic metabolite, DEB. This method will be useful for future studies of 1,3-butadiene exposure and metabolism.https://www.mdpi.com/2305-6304/9/10/247urinary DNA adducts1,3-butadiene<i>bis</i>-N7G-BDLC-MS/MSmercapturic acids
spellingShingle Luke Erber
Samantha Goodman
Caitlin C. Jokipii Krueger
Ivan Rusyn
Natalia Tretyakova
Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
Toxics
urinary DNA adducts
1,3-butadiene
<i>bis</i>-N7G-BD
LC-MS/MS
mercapturic acids
title Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
title_full Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
title_fullStr Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
title_full_unstemmed Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
title_short Quantitative NanoLC/NSI<sup>+</sup>-HRMS Method for 1,3-Butadiene Induced <em>bis</em>-N7-guanine DNA-DNA Cross-Links in Urine
title_sort quantitative nanolc nsi sup sup hrms method for 1 3 butadiene induced em bis em n7 guanine dna dna cross links in urine
topic urinary DNA adducts
1,3-butadiene
<i>bis</i>-N7G-BD
LC-MS/MS
mercapturic acids
url https://www.mdpi.com/2305-6304/9/10/247
work_keys_str_mv AT lukeerber quantitativenanolcnsisupsuphrmsmethodfor13butadieneinducedembisemn7guaninednadnacrosslinksinurine
AT samanthagoodman quantitativenanolcnsisupsuphrmsmethodfor13butadieneinducedembisemn7guaninednadnacrosslinksinurine
AT caitlincjokipiikrueger quantitativenanolcnsisupsuphrmsmethodfor13butadieneinducedembisemn7guaninednadnacrosslinksinurine
AT ivanrusyn quantitativenanolcnsisupsuphrmsmethodfor13butadieneinducedembisemn7guaninednadnacrosslinksinurine
AT nataliatretyakova quantitativenanolcnsisupsuphrmsmethodfor13butadieneinducedembisemn7guaninednadnacrosslinksinurine